Rahul Mutneja, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mutneja’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$2,610
Medicare paid this office $2,610 for 14 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
14 Original Medicare patients in 2024. Average age 74 · Health risk score 3.22. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
The office billed $7,603, Medicare allowed $3,433 and paid $2,610; for 30 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 14 | 30 | 74 | 3.22 | $7,603 | $2,610 |
| 2023 | 81 | 177 | 74 | 2.31 | $41,696 | $13,373 |
| 2022 | 295 | 946 | 73 | 2.32 | $227,773 | $75,847 |
| 2021 | 330 | 1,086 | 74 | 2.79 | $240,421 | $89,527 |
| 2020 | 357 | 985 | 74 | 2.79 | $236,445 | $90,202 |
| 2019 | 419 | 1,439 | 74 | 2.80 | $334,891 | $118,638 |
| 2018 | 210 | 587 | 73 | 2.67 | $143,699 | $52,778 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $5,809 | $98 |
| Return visit (30+ min) | 21 | $1,853 | $88 |
| Test to determine lung volumes using gas dilution or washout | 11 | $97 | $9 |
| Test to examine how well the lungs exchange gases | 12 | $80 | $7 |
2022: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $21,277 | $84 |
| Critical care, first 30-74 minutes | 62 | $15,873 | $185 |
| Return visit (30+ min) | 54 | $8,205 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $6,283 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,669 | $157 |
| New patient visit (45+ min) | 21 | $2,490 | $119 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,204 | $110 |
| Short return visit (20+ min) | 28 | $2,058 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,779 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,399 | $117 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $1,007 | $42 |
| Test to determine lung volumes using gas dilution or washout | 55 | $584 | $10 |
| Test to examine how well the lungs exchange gases | 61 | $484 | $7 |
| Test to measure expiratory airflow and volume | 37 | $267 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $233 | $9 |
2021: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $29,442 | $85 |
| Critical care, first 30-74 minutes | 71 | $18,858 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $9,765 | $61 |
| Return visit (30+ min) | 51 | $7,828 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,585 | $170 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,212 | $114 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,798 | $106 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,746 | $67 |
| New patient visit (45+ min) | 11 | $1,592 | $145 |
| Short return visit (20+ min) | 24 | $1,543 | $59 |
| Test to determine lung volumes using gas dilution or washout | 52 | $565 | $10 |
| Test to examine how well the lungs exchange gases | 57 | $457 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 43 | $370 | $9 |
| Test to measure expiratory airflow and volume | 20 | $148 | $7 |
2020: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $29,999 | $88 |
| Critical care, first 30-74 minutes | 96 | $26,055 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,728 | $174 |
| Return visit (30+ min) | 51 | $5,403 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $4,891 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,016 | $118 |
| New patient visit (45+ min) | 15 | $1,822 | $121 |
| Short return visit (20+ min) | 27 | $1,806 | $60 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,739 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,567 | $63 |
| Test to determine lung volumes using gas dilution or washout | 43 | $430 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 40 | $402 | $10 |
| Test to examine how well the lungs exchange gases | 46 | $345 | $7 |
| Test to measure expiratory airflow and volume | 11 | $79 | $7 |
2019: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 188 | $37,003 | $87 |
| Critical care, first 30-74 minutes | 74 | $23,790 | $187 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,969 | $164 |
| Return visit (30+ min) | 75 | $10,248 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $7,573 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,655 | $113 |
| Long return visit (40+ min) | 33 | $4,962 | $115 |
| New patient visit (60+ min) | 22 | $3,185 | $145 |
| New patient visit (45+ min) | 23 | $3,082 | $134 |
| Short return visit (20+ min) | 26 | $1,710 | $59 |
| Test to determine lung volumes using gas dilution or washout | 88 | $963 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 77 | $925 | $11 |
| Test to examine how well the lungs exchange gases | 96 | $790 | $7 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $464 | $33 |
| Test to measure expiratory airflow and volume | 22 | $157 | $7 |
2018: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $20,506 | $88 |
| Critical care, first 30-74 minutes | 42 | $8,822 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,313 | $171 |
| Return visit (30+ min) | 31 | $3,303 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,659 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $2,644 | $61 |
| Short return visit (20+ min) | 14 | $891 | $59 |
| Test to determine lung volumes using gas dilution or washout | 26 | $261 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $255 | $11 |
| Test to examine how well the lungs exchange gases | 29 | $218 | $8 |
Medicaid work
$5,277 in 2023
Medicaid paid $5,277 for 187 billed services this clinician did in 2023, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 136 | $4,350 |
| Return visit (30+ min) | 39 | $928 |
| TOBACCO NON-USER | 12 | $0 |
| 2023 | 187 | 3 | 22 | $5,277 |
| 2022 | 1,296 | 13 | 27 | $18,583 |
| 2021 | 955 | 10 | 28 | $23,431 |
| 2020 | 853 | 6 | 28 | $28,998 |
| 2019 | 1,126 | 9 | 32 | $26,822 |
| 2018 | 302 | 5 | 33 | $7,154 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 310 | $9,610 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 38 | $2,584 |
| Return visit (30+ min) | 78 | $2,340 |
| New patient visit (30+ min) | 27 | $1,394 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 144 | $734 |
| Short return visit (20+ min) | 30 | $644 |
| Diffusing capacity | 152 | $525 |
| New patient visit (45+ min) | 13 | $501 |
| EVALUATION OF WHEEZING | 29 | $169 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 28 | $83 |
| TOBACCO NON-USER | 202 | $0 |
| Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 163 | $0 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 524 | $16,287 |
| Return visit (30+ min) | 124 | $3,444 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 45 | $2,519 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 43 | $746 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 57 | $252 |
| Diffusing capacity | 60 | $183 |
| TOBACCO NON-USER | 52 | $0 |
| Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 26 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 12 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 12 | $0 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 530 | $16,244 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 145 | $10,207 |
| Return visit (30+ min) | 64 | $2,056 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 44 | $264 |
| Diffusing capacity | 58 | $227 |
| Bp scrn perf rec interval | 12 | $0 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 587 | $15,806 |
| Return visit (30+ min) | 215 | $5,750 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 49 | $4,338 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 69 | $371 |
| EVALUATION OF WHEEZING | 53 | $300 |
| Diffusing capacity | 75 | $257 |
| TOBACCO NON-USER | 25 | $0 |
| Bmi is documented above normal parameters and a follow-up plan is documented | 13 | $0 |
| Bp scrn perf rec interval | 40 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 233 | $6,078 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 16 | $893 |
| EVALUATION OF WHEEZING | 17 | $79 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 17 | $59 |
| Diffusing capacity | 19 | $45 |
Drugs they prescribed that Part D paid
$307,434
Pharmacies billed $307,434 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 537) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
379 generic and 158 brand-name prescriptions · $307,434 in drug cost · 41 antibiotic prescriptions to 31 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breyna | 141 | $21,561 | $153 |
| Spiriva Respimat | 28 | $14,476 | $517 |
| Stiolto Respimat | 14 | $12,748 | $911 |
| Alvesco | 52 | $6,607 | $127 |
| Mycophenolate Mofetil | 16 | $2,457 | $154 |
See all 12 drugs
| Breyna | 141 | $21,561 | $153 |
| Spiriva Respimat | 28 | $14,476 | $517 |
| Stiolto Respimat | 14 | $12,748 | $911 |
| Alvesco | 52 | $6,607 | $127 |
| Mycophenolate Mofetil | 16 | $2,457 | $154 |
| Ipratropium | 28 | $593 | $21 |
| Fluticasone Propionate | 30 | $489 | $16 |
| Albuterol Sulfate Hfa | 16 | $390 | $24 |
| Prednisone | 43 | $388 | $9 |
| Azelastine | 19 | $321 | $17 |
| Amoxicillin-Clavulanate Potass | 12 | $186 | $16 |
| Montelukast | 13 | $97 | $7 |
Year by year
| 2024 | 537 | 166 | 0% (0) | 29% | $307,434 |
| 2023 | 999 | 236 | 0% (0) | 63% | $607,673 |
| 2022 | 1,365 | 233 | 0% (0) | 66% | $863,586 |
| 2021 | 1,133 | 180 | 0% (0) | 64% | $631,710 |
| 2020 | 967 | 177 | None | 67% | $464,168 |
| 2019 | 808 | 169 | 0% (0) | 64% | $439,790 |
| 2018 | 249 | 79 | 0% (0) | 61% | $90,350 |
| 2017 | 66 | 22 | 0% (0) | 61% | $10,544 |
| 2016 | 145 | 46 | 0% (0) | 71% | $27,662 |
| 2015 | 464 | 68 | None | 29% | $35,997 |
| 2014 | 798 | 98 | 3% (22) | 23% | $62,596 |
| 2013 | 546 | 100 | 4% (22) | 25% | $31,605 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Trelegy Ellipta | 143 | $138,147 | $966 |
| Fasenra | 11 | $63,787 | $5,799 |
| Breo Ellipta | 66 | $41,568 | $630 |
| Anoro Ellipta | 53 | $36,817 | $695 |
| Symbicort | 71 | $30,327 | $427 |
| Spiriva Respimat | 45 | $18,179 | $404 |
| Spiriva Handihaler | 14 | $14,027 | $1,002 |
| Advair Hfa | 18 | $10,219 | $568 |
| Incruse Ellipta | 16 | $9,147 | $572 |
| Wixela Inhub | 28 | $8,121 | $290 |
| Albuterol Sulfate Hfa | 108 | $4,354 | $40 |
| Arnuity Ellipta | 12 | $3,026 | $252 |
| Alvesco | 22 | $2,754 | $125 |
| Mycophenolate Mofetil | 18 | $2,493 | $139 |
| Fluticasone Propionate | 62 | $1,140 | $18 |
| Ipratropium | 22 | $1,068 | $49 |
| Ventolin Hfa | 12 | $739 | $62 |
| Montelukast | 33 | $677 | $21 |
| Prednisone | 68 | $636 | $9 |
| Azelastine | 13 | $219 | $17 |
| Omeprazole | 23 | $157 | $7 |
| Azithromycin | 11 | $109 | $10 |
2022: 24 drugs
| Ofev | 14 | $218,426 | $15,602 |
| Trelegy Ellipta | 173 | $145,052 | $838 |
| Breo Ellipta | 179 | $95,867 | $536 |
| Anoro Ellipta | 92 | $55,568 | $604 |
| Symbicort | 89 | $53,990 | $607 |
| Spiriva Handihaler | 31 | $33,896 | $1,093 |
| Spiriva Respimat | 49 | $25,256 | $515 |
| Incruse Ellipta | 25 | $17,424 | $697 |
| Combivent Respimat | 18 | $13,416 | $745 |
| Advair Hfa | 21 | $11,943 | $569 |
| Albuterol Sulfate Hfa | 183 | $8,766 | $48 |
| Wixela Inhub | 26 | $8,727 | $336 |
| Advair Diskus | 16 | $8,466 | $529 |
| Flovent Hfa | 20 | $7,812 | $391 |
| Fluticasone-Salmeterol | 18 | $4,368 | $243 |
| Mycophenolate Mofetil | 11 | $1,669 | $152 |
| Ventolin Hfa | 17 | $1,033 | $61 |
| Prednisone | 99 | $845 | $9 |
| Montelukast | 41 | $702 | $17 |
| Fluticasone Propionate | 43 | $694 | $16 |
| Omeprazole | 42 | $303 | $7 |
| Azithromycin | 18 | $152 | $8 |
| Levocetirizine Dihydrochloride | 11 | $145 | $13 |
| Furosemide | 25 | $100 | $4 |
2021: 18 drugs
| Breo Ellipta | 155 | $79,262 | $511 |
| Trelegy Ellipta | 93 | $70,201 | $755 |
| Spiriva | 61 | $61,537 | $1,009 |
| Symbicort | 72 | $50,829 | $706 |
| Anoro Ellipta | 83 | $49,818 | $600 |
| Incruse Ellipta | 19 | $17,556 | $924 |
| Spiriva Respimat | 14 | $9,046 | $646 |
| Albuterol Sulfate Hfa | 159 | $7,224 | $45 |
| Advair Hfa | 11 | $6,202 | $564 |
| Advair Diskus | 12 | $5,654 | $471 |
| Wixela Inhub | 13 | $4,030 | $310 |
| Flovent Hfa | 11 | $3,835 | $349 |
| Proair Hfa | 16 | $1,407 | $88 |
| Prednisone | 125 | $1,024 | $8 |
| Montelukast | 58 | $887 | $15 |
| Fluticasone Propionate | 43 | $796 | $19 |
| Omeprazole | 19 | $194 | $10 |
| Azithromycin | 12 | $82 | $7 |
2020: 19 drugs
| Esbriet | 12 | $119,141 | $9,928 |
| Trelegy Ellipta | 80 | $61,043 | $763 |
| Spiriva | 68 | $53,994 | $794 |
| Breo Ellipta | 110 | $50,153 | $456 |
| Anoro Ellipta | 96 | $44,902 | $468 |
| Symbicort | 54 | $32,014 | $593 |
| Incruse Ellipta | 29 | $16,366 | $564 |
| Stiolto Respimat | 19 | $13,316 | $701 |
| Advair Hfa | 11 | $5,853 | $532 |
| Albuterol Sulfate Hfa | 63 | $3,913 | $62 |
| Flovent Diskus | 12 | $3,217 | $268 |
| Azelastine-Fluticasone | 12 | $2,005 | $167 |
| Proair Hfa | 19 | $1,366 | $72 |
| Ventolin Hfa | 23 | $1,321 | $57 |
| Fluticasone Propionate | 57 | $987 | $17 |
| Montelukast | 61 | $879 | $14 |
| Prednisone | 76 | $550 | $7 |
| Omeprazole | 23 | $303 | $13 |
| Azithromycin | 16 | $220 | $14 |
2019: 19 drugs
| Esbriet | 21 | $226,835 | $10,802 |
| Breo Ellipta | 98 | $35,528 | $363 |
| Anoro Ellipta | 58 | $27,362 | $472 |
| Spiriva | 34 | $27,005 | $794 |
| Symbicort | 49 | $25,306 | $516 |
| Trelegy Ellipta | 39 | $24,978 | $640 |
| Advair Diskus | 12 | $8,699 | $725 |
| Incruse Ellipta | 21 | $7,887 | $376 |
| Ventolin Hfa | 58 | $3,329 | $57 |
| Albuterol Sulfate Hfa | 38 | $2,398 | $63 |
| Proair Hfa | 20 | $1,537 | $77 |
| Esomeprazole Magnesium | 17 | $1,484 | $87 |
| Fluticasone Propionate | 46 | $714 | $16 |
| Doxycycline Hyclate | 12 | $497 | $41 |
| Prednisone | 80 | $486 | $6 |
| Montelukast | 25 | $484 | $19 |
| Furosemide | 31 | $175 | $6 |
| Azithromycin | 23 | $149 | $6 |
| Omeprazole | 13 | $122 | $9 |
2018: 7 drugs
| Advair Diskus | 35 | $18,822 | $538 |
| Symbicort | 23 | $8,406 | $365 |
| Spiriva | 13 | $7,485 | $576 |
| Ventolin Hfa | 31 | $1,697 | $55 |
| Fluticasone Propionate | 32 | $401 | $13 |
| Prednisone | 24 | $96 | $4 |
| Furosemide | 12 | $32 | $3 |
2016: 6 drugs
| Spiriva | 19 | $6,380 | $336 |
| Symbicort | 17 | $4,973 | $293 |
| Incruse Ellipta | 14 | $3,915 | $280 |
| Advair Diskus | 12 | $3,838 | $320 |
| Ventolin Hfa | 11 | $572 | $52 |
| Prednisone | 12 | $53 | $4 |
2015: 10 drugs
| Atorvastatin | 25 | $257 | $10 |
| Tamsulosin | 13 | $209 | $16 |
| Gabapentin | 14 | $201 | $14 |
| Omeprazole | 17 | $192 | $11 |
| Metoprolol | 13 | $166 | $13 |
| Amlodipine Besylate | 37 | $165 | $4 |
| Lisinopril | 38 | $157 | $4 |
| Hydrochlorothiazide | 21 | $127 | $6 |
| Metformin | 26 | $111 | $4 |
| Furosemide | 16 | $68 | $4 |
2014: 23 drugs
| Advair Diskus | 20 | $7,880 | $394 |
| Lantus | 18 | $6,511 | $362 |
| Januvia | 11 | $3,227 | $293 |
| Crestor | 16 | $3,040 | $190 |
| Proair Hfa | 17 | $1,081 | $64 |
| Atorvastatin | 49 | $666 | $14 |
| Metoprolol | 27 | $612 | $23 |
| Lisinopril | 74 | $336 | $5 |
| Metformin | 45 | $303 | $7 |
| Gabapentin | 25 | $303 | $12 |
| Alendronate | 28 | $206 | $7 |
| Amlodipine Besylate | 46 | $184 | $4 |
| Tamsulosin | 14 | $173 | $12 |
| Hydrochlorothiazide | 34 | $162 | $5 |
| Carvedilol | 23 | $147 | $6 |
| Tramadol | 17 | $142 | $8 |
| Famotidine | 13 | $130 | $10 |
| Donepezil | 13 | $112 | $9 |
| Enalapril Maleate | 13 | $94 | $7 |
| Losartan | 14 | $94 | $7 |
| Omeprazole | 12 | $77 | $6 |
| Ranitidine | 13 | $76 | $6 |
| Simvastatin | 14 | $71 | $5 |
2013: 17 drugs
| Lantus | 18 | $4,690 | $261 |
| Humalog | 12 | $3,831 | $319 |
| Crestor | 12 | $2,109 | $176 |
| Diovan | 11 | $1,395 | $127 |
| Proair Hfa | 11 | $792 | $72 |
| Metformin | 42 | $350 | $8 |
| Omeprazole | 24 | $341 | $14 |
| Atorvastatin | 15 | $275 | $18 |
| Ramipril | 12 | $207 | $17 |
| Tamsulosin | 12 | $189 | $16 |
| Simvastatin | 25 | $168 | $7 |
| Hydrochlorothiazide | 16 | $165 | $10 |
| Amlodipine Besylate | 28 | $162 | $6 |
| Tramadol | 20 | $154 | $8 |
| Alendronate | 20 | $138 | $7 |
| Lisinopril | 32 | $135 | $4 |
| Metoprolol | 12 | $71 | $6 |
Money from drug and device companies
$372 in 2022
| 2022 | 2 | 3 | None | $372 |
| 2019 | 2 | 2 | None | $219 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biosense Webster | Carto 3 | $247 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $125 | 1 payment
|
See all 3 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2022-10-27 | None | $125 |
| Biosense Webster | Meals · 2022-10-18 | Carto 3 | $123 |
| Biosense Webster | Meals · 2022-10-18 | Carto 3 | $123 |
See earlier years (2019)
2019: $219
| GlaxoSmithKline | Trelegy Ellipta | $118 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $101 | 1 payment
|
Professional record
- NPI
- 1700132263
- Licence
- CT 56850
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Student in a training program (390200000X)
- Mailing address
- 263 Farmington Ave, Farmington, CT, 06030
- NPI first listed
- 2012-08-01
- NPI last updated
- 2024-05-08
- NPI record certified
- 2024-05-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.